The above experiments suggest that OA may reduce the expression of PRMT5 and liver fibrosis-related indicators by inhibiting SIRT7 from interacting with PRMT5 and thereby stimulate the cGAS-STING pathway. Here, PRMT5 is linked to Hepatic fibrosis.